{"organizations": [], "uuid": "4dd3e293e924d94f1169ad735d95b12b3b504152", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180220.html", "section_title": "Archive News &amp; Video for Tuesday, 20 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-genkyotexs-gkt831-halts-tumor-prom/brief-genkyotexs-gkt831-halts-tumor-promoting-effect-of-cancer-associated-fibroblasts-in-new-preclinical-study-idUSFWN1QA10O", "country": "US", "domain_rank": 408, "title": "BRIEF-Genkyotex's GKT831 Halts Tumor Promoting Effect Of Cancer Associated Fibroblasts In New Preclinical Study", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.008, "site_type": "news", "published": "2018-02-21T01:13:00.000+02:00", "replies_count": 0, "uuid": "4dd3e293e924d94f1169ad735d95b12b3b504152"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-genkyotexs-gkt831-halts-tumor-prom/brief-genkyotexs-gkt831-halts-tumor-promoting-effect-of-cancer-associated-fibroblasts-in-new-preclinical-study-idUSFWN1QA10O", "ord_in_thread": 0, "title": "BRIEF-Genkyotex's GKT831 Halts Tumor Promoting Effect Of Cancer Associated Fibroblasts In New Preclinical Study", "locations": [], "entities": {"persons": [{"name": "genkyotex", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 20 (Reuters) - GENKYOTEX SA:\n* GENKYOTEXâ€™S LEAD PRODUCT CANDIDATE, GKT831, HALTS THE TUMOR PROMOTING EFFECT OF CANCER ASSOCIATED FIBROBLASTS IN NEW PRECLINICAL STUDY Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-21T01:13:00.000+02:00", "crawled": "2018-02-21T21:33:01.001+02:00", "highlightTitle": ""}